Media Resources

Date	Title
Aug 08, 2022	Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
Aug 04, 2022	GBT Announces New Employment Inducement Grants
Aug 03, 2022	GBT Announces Participation at the Wedbush PacGrow Healthcare Conference
Jul 29, 2022	GBT to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
Jul 26, 2022	MHRA Grants Marketing Authorization for GBT’s Oxbryta® (voxelotor) for Use in Great Britain for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older

Media and Investor Contact

Steven Immergut
SVP, Head of Corporate Communications and Investor Relations
650-410-3258
simmergut@gbt.com